155 related articles for article (PubMed ID: 9210882)
1. Clinical evaluation of anti-tumor effects of Lentinan combined with chemotherapy in the treatment of various malignancies.
Qing ZJ; Ming QX; Zhong TF
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():1-8. PubMed ID: 9210882
[No Abstract] [Full Text] [Related]
2. [TS-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer].
Nagahashi S; Suzuki H; Nishiwaki M; Okuda K; Kurosawa Y; Terada S; Sugihara T; Andou K; Hibi T
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1999-2003. PubMed ID: 15570928
[TBL] [Abstract][Full Text] [Related]
3. [Problems in surgical adjuvant therapy].
Taguchi T; Hara N; Nakajima T; Hojo K; Miura S
Gan To Kagaku Ryoho; 1990 May; 17(5):975-91. PubMed ID: 2334177
[No Abstract] [Full Text] [Related]
4. Lentinan with S-1 and paclitaxel for gastric cancer chemotherapy improve patient quality of life.
Kataoka H; Shimura T; Mizoshita T; Kubota E; Mori Y; Mizushima T; Wada T; Ogasawara N; Tanida S; Sasaki M; Togawa S; Sano H; Hirata Y; Ikai M; Mochizuki H; Seno K; Itoh S; Kawai T; Joh T
Hepatogastroenterology; 2009; 56(90):547-50. PubMed ID: 19579640
[TBL] [Abstract][Full Text] [Related]
5. [A case of advanced gastric cancer with hepatic metastasis successfully treated by combined chemotherapy with UFT and lentinan].
Yamada T; Watanabe A; Sadou S; Nishinuma T; Tsurui H; Watanabe T; Nakano H
Gan To Kagaku Ryoho; 2000 Feb; 27(2):281-4. PubMed ID: 10700901
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of lymphocyte subset change as an indicator for predicting survival time and effectiveness of treatment with the immunopotentiator lentinan.
Matsuoka H; Yano K; Seo Y; Saito T; Tomoda H; Tsurumoto S
Anticancer Res; 1995; 15(5B):2291-6. PubMed ID: 8572640
[TBL] [Abstract][Full Text] [Related]
7. A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group.
Nakano H; Namatame K; Nemoto H; Motohashi H; Nishiyama K; Kumada K
Hepatogastroenterology; 1999; 46(28):2662-8. PubMed ID: 10522061
[TBL] [Abstract][Full Text] [Related]
8. [US-Japan Cooperative Cancer Research Program--adjuvant and neo-adjuvant chemotherapy].
Ogawa M
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1175-9. PubMed ID: 3566311
[No Abstract] [Full Text] [Related]
9. [Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion].
Kawaoka T; Yoshino S; Hazama S; Tangoku A; Oka M
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1562-5. PubMed ID: 14619464
[TBL] [Abstract][Full Text] [Related]
10. [Pilot study of TS-1 combined with lentinan in patients with unresectable or recurrent advanced gastric cancer].
Nimura H; Mitsumori N; Tsukagoshi S; Nakajima M; Atomi Y; Suzuki S; Kusano M; Yoshiyuki T; Tokunaga A
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1289-96. PubMed ID: 14518408
[TBL] [Abstract][Full Text] [Related]
11. [A case of long survival with UFT and lentinan treatment in a patient with peritoneal metastasis of gastric carcinoma].
Nakayama H; Aoki N; Hayashi S; Wakabayashi K; Karube H; Ogame H; Aoki H; Sakamoto N; Masuda H; Hemmi A
Gan To Kagaku Ryoho; 2004 Feb; 31(2):241-3. PubMed ID: 14997760
[TBL] [Abstract][Full Text] [Related]
12. [Seven patients with stage IVb advanced gastric cancer who were treated with preoperative chemotherapy].
Yamanaka N; Morisaki T; Nakamura K; Ogawa T; Uchiyama A; Noshiro H; Kuroiwa T; Chijiiwa K; Tanaka M
Gan To Kagaku Ryoho; 2000 Mar; 27(3):459-63. PubMed ID: 10740641
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of TS-1 and lentinan combination immunochemotherapy in advanced or recurrent gastric cancer--pilot study aiming at a randomized trial].
Kimura Y; Iijima S; Kato T; Tsujie M; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E; Kikkawa N; Matsuura N
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1125-30. PubMed ID: 12938267
[TBL] [Abstract][Full Text] [Related]
14. [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer].
Nimura H; Mitsumori N; Takahashi N; Kashimura H; Takayama S; Kashiwagi H; Yanaga K
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():106-9. PubMed ID: 16897983
[TBL] [Abstract][Full Text] [Related]
15. [Pro and contra early systemic therapy of malignant tumors].
Oldenkott B; Boewer C
Med Klin (Munich); 1996 Dec; 91(12):780-90. PubMed ID: 9082165
[No Abstract] [Full Text] [Related]
16. [Concurrent chemoradiotherapy update].
Reboul F; Vincent P; Chauvet B; Alfonsi M; Berger C; Serin D
Bull Cancer; 1999 Jan; 86(1):77-83. PubMed ID: 10029709
[No Abstract] [Full Text] [Related]
17. [Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion].
Kagawa R; Nakayama N; Yamaguchi T; Sakata S; Tada M
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1989-94. PubMed ID: 12465402
[TBL] [Abstract][Full Text] [Related]
18. [Clinical trial of non-specific immunotherapy using Lentinan in advanced or recurrent gastric cancer].
Yoshino S; Oka M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2239-43. PubMed ID: 19106583
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced colorectal and gastric cancer with 5-fluorouracil and calcium n-methyltetrahydrofolate.
Casali A; Tonachella R; Tropea F; Verri C; Paoletti G; Gionfra T; Modugno G; Gallo Curcio C
J Chemother; 1989 Jul; 1(4 Suppl):1212-4. PubMed ID: 16312838
[No Abstract] [Full Text] [Related]
20. [A case of advanced gastric cancer (type 3) with pyloric stenosis, multiple liver and lymph node metastases responding to UFT-E granules and lentinan].
Takemura T; Takahashi S; Yoshikawa T; Kondo M
Gan To Kagaku Ryoho; 2000 Jan; 27(1):107-11. PubMed ID: 10660741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
